High-dose donor bone marrow infusions to enhance allograft survival: The effect of timing

Transplantation

Volumn 63, Issue 1, 1997, Pages 7-11

  Ricordi, Camillo ^a,c   Karatzas, Theodore ^a   Nery, Jose ^a   Webb, Marc ^a   Selvaggi, Gennaro ^a   Fernandez, Luis ^b   Khan, Farrukh A ^a   Ruiz, Phillip ^a   Schiff, Eugene ^a   Olson, Leslie ^a   Fernandez, Hugo ^a   Bean, Judy ^a   Esquenazi, Violet ^a   Miller, Joshua ^a,b   Tzakis, Andreas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031034011     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701150-00003     Document Type: Article

References (24)

1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
2. Monaco AP, Wood ML. Studies on heterologous antilymphocyte serum in mice VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc 1970; 2: 489.
3. Thomas JM, Carver FM, Foil MB. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1983; 36: 104.
4. Ricordi C, Murase N, Rastellini C, Behboo R, Demetris AS, Starzl TE. Indefinite survival of rat islet allograft following infusion of donor bone marrow without cytoablation. Cell Transplant 1996; 5: 53.
5. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal mice. Blood 1993; 81: 2566.
6. Harrison DE. Competitive repopulation in unirradiated normal recipients. Blood 1993; 81: 2473.
7. Bienzle D, Abrams-Ogg ACG, Kruth SA, et al. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 1994; 91: 350.
8. Carter RF, Abrams-Ogg ACG, Dick JE, et al. Autologous transplantation of canine long term marrow culture cells genetically marked by retroviral vectors. Blood 1992; 79: 356.
9. Strong M. Seattle protocol: vertebral body recovery for bone marrow. (PRO-550G) 1992; 1.
10. Ricordi C, Ed. Methods in cell transplantation. Austin, TX: R.G. Landes, 1995: 619.
11. Opelez G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
12. De Waal LP, van Twuyver E. Blood transfusions and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation? Crit Rev Immunol 1991; 10: 417.
13. Langaaij EL, Henneman IPH, Ruigrok M, et al. Effect of one HLA-DR antigen matched and completely HLA-DR mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
14. Monaco AP, Clark AW, Wood ML, Sahyoun AL, Codish SD, Brown RW. Possible active enhancement of a human cadaver renal allograft with antilymphocytic serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 1976; 79: 384.
15. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
16. Fontes, P, Rao A, Demetris AJ, et al. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
17. Ferrebee JW, Atkins L, Lochte HL. The collection, storage and preparation of viable cadaver marrow for intravenous use. Blood 1959; 14: 140.
18. Sharp TG, Sachs DH, Mathews JG. Harvest of human bone marrow directly from bone. J Immunol Methods 1984; 69: 187.
19. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a probable basis of organ transplant acceptance and tolerance. Immunol Today 1993; 14: 326.
20. Thomas J, Carver M, Cunnigham P, Park K, Gonder J, Thomas F. Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow. Transplantation 1987; 43: 332.
21. Wood ML, Monaco AP, Gozzo JJ, Liegois A. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971; 3: 676.
22. Caridis T, Liegois A, Barrett J, Monaco AP. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant Proc 1973; 5: 671.
23. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995; 9: 437.
24. Garcia-Morales R, Esquenazi V, Zucker K, et al. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 1996; 62: 1149.